Skip to main content
All lobbying filings

OGR

Lobbying for GENENTECH INC · biotechnology company

 Filing 4th Quarter - Report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 17, 2026
Income
$70,000.00
What the client paid this registrant for the period.
Client based in
California

Official filing document

 Government bodies contacted 2
  • HOUSE OF REPRESENTATIVES
  • SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Lobbying activity 1
Health Issues

Issues related to public health preparedness. Issues related to access to drugs for minority communities. Issues related to healthcare education and screening. Issues related to 340B Reform. Issues related to PBM Reform.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem